Introduction Emerging and advanced technologies in the field of Artificial Intelligence (AI)
represent promising methods to predict and diagnose neurodegenerative diseases, such as …

There have been considerable progress documenting the properties, strengths and
limitations of web-based cognitive assessments. For the three types of assessments …

The disease trajectory and healthcare requirements of patients with young‐onset dementia
(YOD) differ from those of older patients. Accurate data about YOD is crucial to improve …

Background Both memory clinic professionals and patients see value in digital tools, yet
these hardly find their way to clinical practice. We explored the usability of a digital tool to …

Background The use of amyloid-PET in dementia workup is upcoming. At the same time,
amyloid-PET is costly and limitedly available. While the appropriate use criteria (AUC) aim …

INTRODUCTION We developed a multimarker blood test result interpretation tool for the
clinical dementia practice, including phosphorylated (P‐) tau181, amyloid‐beta (Abeta) …

Introduction A better understanding of the earliest stages of Alzheimer's disease (AD) could
expedite the development or administration of treatments. Large population biobanks hold …

Introduction: A better understanding of the earliest stages of Alzheimer's disease (AD) could
expedite the development or administration of treatments. Large population biobanks hold …

Cognitive testing is an essential part of clinical diagnostics and clinical trials in Alzheimer's
disease. Digital cognitive tests hold a great opportunity to provide more versatile and cost …

The increasing prevalence of people with Parkinson's disease (PD) necessitates a high
priority for finding interventions to delay or even prevent the onset of PD. There is …